GlassScriptPhysician profile
Amy N Bowers
NPI 1720640170
$1,387.66
in general payments reported to CMS, 2019-2025
19 companies · $160 in 2025
The $160 reported for 2025 was less than what a typical Infectious Disease provider received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $108 · 2020: $327 · 2021: $323 · 2022: $35.95 · 2023: $94.57 · 2024: $339 · 2025: $160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $594.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $593.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $238.59 | 2024 | Biktarvy |
| Janssen Pharmaceuticals, INC | $148.75 | 2020-2021 | |
| Abbvie INC. | $146.61 | 2025 | |
| Novo Nordisk INC | $140.67 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $124.03 | 2021-2024 | Farxiga |
| Amarin Pharma, INC. | $105.66 | 2020-2021 | |
| Lilly USA, LLC | $101.24 | 2020-2021 | |
| Alexion Pharmaceuticals, INC. | $94.57 | 2023 | |
| Mylan Specialty L.P. | $58.07 | 2020-2021 | |
| Philips North America LLC | $57.86 | 2019 | |
| Amgen INC. | $32.76 | 2021 | |
| Xeris Pharmaceuticals, INC. | $28.32 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $24.02 | 2022 | |
| Taiho Oncology, INC. | $17.30 | 2021 | |
| Genzyme Corporation | $15.62 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $15.28 | 2021 | |
| Alkermes, INC. | $13.57 | 2025 | Aristada, Lybalvi |
| Esperion Therapeutics, INC. | $12.81 | 2021 | |
| Genentech USA, INC. | $11.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Bowers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.